API manufacturing

Dr Sanjay Chaturvedi, ED and CEO, IOL Chemicals and Pharmaceuticals stresses that as the Indian pharmaceutical industry continues…

While formulation generics flounders a bit, the data show that the Indian API industry has done better, with a five-year revenue…

CMOs can benefit from investing in capabilities and expertise to produce and handle sensitive biologics, as the marketed drugs…

The company did not reveal the name of the global pharmaceutical firm and the value of the deal

Dr RB Smarta, CMD, Interlink and VP, HADSA elaborates on ten trends that will greatly influence the pharma industry in 2021-22

Richa Mahindru, Domain Leader, Pharma and Life Sciences Practice, and Ishani Jain, Member, Pharma and Life Sciences Practice…

The Indian government is committed to achieving its ''Pharma Vision 2020'', which aims to make the country a global leader in drug…

Indian pharma companies are more likely to engage in contract/excess capacity API manufacture than companies in the other small…

It is an interim measure taken by the central government to ensure that all necessary projects or activities in respect of bulk…

Government order exempts continuous process units such as pharmaceuticals, APIs etc